| Literature DB >> 33198121 |
Lan Lin1,2, Jianping Xu2.
Abstract
Fungi can produce myriad secondary metabolites, including pigments. Some of these pigments play a positive role in human welfare while others are detrimental. This paper reviews the types and biosynthesis of fungal pigments, their relevance to human health, including their interactions with host immunity, and recent progresses in their structure-activity relationships. Fungal pigments are grouped into carotenoids, melanin, polyketides, and azaphilones, etc. These pigments are phylogenetically broadly distributed. While the biosynthetic pathways for some fungal pigments are known, the majority remain to be elucidated. Understanding the genes and metabolic pathways involved in fungal pigment synthesis is essential to genetically manipulate the production of both the types and quantities of specific pigments. A variety of fungal pigments have shown wide-spectrum biological activities, including promising pharmacophores/lead molecules to be developed into health-promoting drugs to treat cancers, cardiovascular disorders, infectious diseases, Alzheimer's diseases, and so on. In addition, the mechanistic elucidation of the interaction of fungal pigments with the host immune system provides valuable clues for fighting fungal infections. The great potential of fungal pigments have opened the avenues for academia and industries ranging from fundamental biology to pharmaceutical development, shedding light on our endeavors for disease prevention and treatment.Entities:
Keywords: antitumor; azaphilones; carotenoids; fungal pigments; medical roles; melanin; polyketides
Year: 2020 PMID: 33198121 PMCID: PMC7711509 DOI: 10.3390/jof6040280
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Figure 1Structure of representative carotenoids.
Figure 2Azaphilonoid scaffold.
Figure 3Azaphilone pigments derived from the yeast Monascus.
Figure 4Chemical structure of monacolin K, monascin and ankaflavin. (A) Monacolin K; (B) Monascin and ankaflavin.
Figure 5Chemical structure of the pigment sclerotiorin produced by Penicillum sclerotiorum 2AV2.
Figure 6Mechanisms of fungal polyketide biosynthesis.
Figure 7Shikimate pathway leading to biosynthesis of p-terphenyls.
Figure 8Simplified scheme of the biosynthetic pathways for β-carotene (black arrows) and the astaxanthin and neurosporaxanthin (blue arrows) from GPP.
Figure 9Chalciporone.
Figure 10Cinnabarinic acid.
Figure 11The indolic compounds 6-hydroxy-1H-indole-3-carboxaldehyde (left) and 6-hydroxy-1H-indole-3-acetamide (right) isolated from the fruiting bodies of Agrocybe cylindracea (middle, insert image).
Fungal pigments with antitumor activities.
| Fungal Sources | Fungal Species/Strain | Isolated Compound | Chemical Nature | Tumor Model/Cell Lines/Target Enzyme | Activity/Active Concentration | References |
|---|---|---|---|---|---|---|
|
| Monascin & ankaflavin | Azaphilones | Ames test and Peroxynitrite-and UVB-induced mouse skin carcinogenesis model | Accelerate the mutagen decomposition | Ho et al. [ | |
| Ankaflavin | HepG2, A549 #/IC50 | 15 μg/mL | Su et al. [ | |||
|
| Monaphilone A | HEp-2, WiDr #/IC50 | 72.1, 55.8 μM | Hsu et al. [ | ||
| Rubropunctatin | BGC-823 #/IC50 and in vivo mouse model | 12.57 μM | Zheng et al. [ | |||
|
| Monascopyridine C & D | IHKE (kidney epithelial cell) CCK8 assay/EC50 | 20.7–43.2 μmol/L | Knecht et al. [ | ||
| Glutamic acid derivative of | B16F10 (mouse melanoma cells) | 30% inhibition | Jo et al. [ | |||
|
| Monascuspiloin | Monascin analog | PC-3 tumors of nude mice | 42.5% inhibition (in vivo) | Chiu et al. [ | |
| Endophytic fungi | A fungus endophytic to | Ergoflavin | Xanthenes | ACHN (renal cell carcinoma), H460 (non-small-cell lung carcinoma), Panc1(pancreas), HCT116 (colon cancer), and Calu-1 (lung carcinoma) | 1.2, 4.0, 2.4, 8.0, 1.5μM/IC50 | Deshmukh et al. [ |
| Dicerandrol A, | Xanthenes | A549, HCT116 #/IC50 | 7.0, 7.0 μg/mL | Wagenaar & Clardy [ | ||
| Chaetomugilides A–C | Azaphilone alkaloids | HepG-2# | 1.7−3.4 μM/IC50 | Li et al. [ | ||
| Penexanthone A | Xanthones | A panel of cancer cell lines | 1−17 μM/IC50 | Cao et al. [ | ||
| Chaetomugilin A | Azaphilone alkaloids | P388(murine), HL-60 (human) leukemia | 8.7, 7.3 μM/IC50 | Yasuhide et al. [ | ||
| Marine fungi | TMC 256 A1 | Naphtho-γ-pyrone | MCF-7 & MDA-MB-435 (breast carcinoma), Hep3B & Huh7 (hepatoma), SNB19 & U87 MG (glioblastoma) | 19.92−47.98 μM/IC50 | Sakurai et al. [ | |
| Pinophilin A | Hydrogenated azaphilones | Mammalian DNA | 48.6–55.6 μM/IC50 | Myobatake et al. [ | ||
| Chloroazaphilones | ACHN, 786-O, OS-RC-2 | 4.4, 3.0, 3.9 μM/IC50 | Luo et al. [ | |||
| chloroazaphilones | MGC-803, HO8910 # | 6.6, 9.7 μM/IC50 | Sun et al. [ | |||
| Bostrycindeoxybostrycin | Anthraquinones | A549, HepG2 # | 2.64, 5.90 μg/mL | Xia et al. [ | ||
| (+)-formylanserinone B | Pentaketides | MDA-MB-435 # | 2.90 μg/mL | Gautschi et al. [ | ||
| Fungi in special habitats | Berkchaetoazaphilones A, C | Azaphilones | Caspase-1 | 150,25,50 μM/IC50 | Stierle et al. [ | |
| Coniellin A | Azaphilones | MDA-MB-231# | 4.4 μM /IC50 and suppress tumor migration by 98% at 10 μM | Yu et al. [ | ||
| Macrofungi (mushroom) |
| Subvellerolactone B, | Sesquiterpene hydroxylactones | A549, SK-MEL-2 #, HCT-15 | 26.5, 18.3, 14.2 μM/IC50 | Kim et al. [ |
|
| Grifolin derivatives 1–3 | Phenolic compounds | A549, | 5.0–9.0 μg/mL | Song et al. [ | |
|
| Albatrellin | Meroterpenoid | HepG2 | 1.55 μg/mL | Yang et al. [ | |
|
| Grifolin, | Phenolic compounds | SW480 & HT29 | 35.4, 30.7μM/IC50 | Yaqoob et al. [ |
† rubropunctatin & monascorubin. ξ Matrix metalloproteinase-3 (MMP-3). # a variety of human cancer cell lines: A549 (lung adenocarcinoma), HepG2 (heptoblasoma), HEp-2 (laryngeal carcinoma), WiDr (colon adenocarcinoma), MGC-803 (gastric adenocarcinoma), HO8910 (ovarian cancer), HL-60 (promyelocytic leukemia), HCT-116 (colon cancer), MDA-MB-435 (breast cancer), Y79 (retinoblastoma), LOX IMVI (melanoma), SK-MEL-2 (skin melanoma), HCT-15 (colon adenocarcinoma).
Figure 12Structure of helicusin A, a pigment from marine fungus Bartalinia robillardoides.
Antimicrobial activities of fungal pigments.
| Fungal Sources | Fungal Species/Strain | Bioactive Component | Target Microbes 1 | Antimicrobial Assay 2 | Reference |
|---|---|---|---|---|---|
| Marine sponge-associated, Indonesia |
| Yellow pigment | MIC: 1000 μg/mL | Sibero et al. [ | |
| Deep sea, West Pacific Ocean | Chaetoviridide A, B | MIC: 7.3–7.8μg/mL | Wang et al. [ | ||
| Spoiled onion |
| Red exopigment |
| Agar diffusion assay showing inhibition zone (diameter 1.5–2.3 cm) | Patil et al. [ |
| Tropical Culture Collection André Tosello (Campinas, SP, Brazil). | Orange pigments (monascorubrin, rubropunctatin) | Foodborne bacterium | Radial diffusion assay showing inhibition zone (diameter 0.15 cm) | Vendruscolo et al. [ | |
| Stressed environment |
| Reddish orange pigment | Well diffusion assay showing inhibition zone (diameter 1.6–2.9 cm) | Mani et al. [ | |
| Western Ghats forest, India | Yellow pigments |
| MIC: 12.5 μg/mL | Saravanan & Radhakrishnan [ | |
| Persian type culture collection (PTCC), Tehran, Iran | Carotenoid pigments | Disk diffusion assay showing inhibition zone (diameter 0.9–1.1 cm) | Yolmeh et al. [ | ||
| Endophyte on marine brown algae, eastern China |
| Asperversin, brevianamide M | Disk diffusion assay showing inhibition zone (diameter 2.0–2.2 cm) | Miao et al. [ | |
| Endophyte on leaves of | 14-hydroxyltajixanthone | Fungus- | MIC: 25 μg/mL | Wu et al. [ | |
| Mangrove rhizosphere soil | Penicilones B−D | MRSA ( | MIC: 3.13–6.25 μg/mL | Chen et al. [ |
1, MRSA: Methicillin-resistant Staphylococcus aureus; 2, MIC: minimum inhibitory concentrations.
Figure 13Structures of azaphilones.